Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 26
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Caribou Biosciences Inc
CRBU
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.5328
-0.0272
-4.86%
Ult. Agg.: Oct 23, 7:46 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Caribou Biosciences Financials
Caribou Biosciences (CRBU) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: Dow Jones, Nasdaq 100 Futures Decline as Iran Mocks US Economy, Trump Sparks Bipartisan Backlash — STZ, PENG, LEVI in Focus
U.S. stock futures were lower on Wednesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Tuesday's higher close.
Rishabh Mishra
Levi Strauss, Constellation Brands and 3 Stocks to Watch Heading Into Wednesday
Stocks in focus: Levi Strauss and Applied Digital report earnings; Caribou halts programs; Constellation raises guidance; Richardson reports.
Avi Kapoor
PRO
Caribou Biosciences Q2 EPS $(0.24) Beats $(0.32) Estimate, Sales $1.499M Miss $2.279M Estimate
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.32) by 25 percent. This is a 31.43 percent increase over losses of $(0.35) per share from
Benzinga Newsdesk
PRO
Caribou Biosciences Q1 EPS $(0.26) Beats $(0.31) Estimate, Sales $2.397M Beat $2.241M Estimate
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 39.53 percent increase over losses of $(0.43) per share
Benzinga Newsdesk
Insights into Caribou Biosciences Q4 Earnings
Benzinga Insights
PRO
Caribou Biosciences Q4 EPS $(0.28) Beats $(0.33) Estimate, Sales $3.941M Beat $2.610M Estimate
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.33) by 14.37 percent. This is a 28.21 percent increase over losses of $(0.39) per share
Benzinga Newsdesk
